Navigation Links
Chew That Fat Away

Some dreams may come true; for fat people and inventors.

Scientists have always sought to find the pill that cures obesity and those of Britain are no exception. //Currently, two thirds of the population can be described as obese.

The Wellcome Trust has decided to put a morbidly obese figure of 2.2 million pounds before Professor Steve Bloom and his team, of Imperial College London.

Bloom’s quest is to create a chewing gum or nasal spray to allay hunger pangs, which can be, used for life and thereby curb obesity.

The scientist who had faced a dearth of funds for his project explains that the pancreas produces a chemical- a hormone pancreatic polypeptide (PP) that suppresses hunger pangs once the stomach is full.

Some people have pancreatic tumors and in this case more than required amounts of PP is produced, rendering the person chronically thin.

Says Bloom, "Developing a treatment based on natural appetite suppression, mimicking our body's response to being full, has the potential to be safe and effective. We believe pancreatic polypeptide may be the answer.” His works were published in The New England Journal of Medicine in 2003.

Early tests have shown moderate doses of the hormone pancreatic polypeptide (PP) can reduce the amount of food eaten by healthy volunteers by 15 to 20 per cent. Mice given the drug lost 15 per cent of their body weight in a week.

The hormone appears to have no side effects, which are crucial for a treatment that might be taken long-term. People with PP-secreting tumors who have lived with high levels of the hormone for more than a decade suffer no ill effects other than being thin.

Beating other fat reducing methods like drugs whose effects are not permanent and bariatric surgery, which is risky, a chewing gum that helps reduce weight may be the best answer to Britain’s expanding figures of obesity.

For Bloom who was turned down by probab le sponsor pharmaceutical companies, as hormones cannot be patented and for many others, this may be the ultimate dream.


AN
'"/>




Related medicine news :

1. Juices are Best! but which one?
2. Pomegranate Juice May Be The Next Best Thing For People With Heart Disease
3. Pomegranate Juice Is Helpful In Arresting Osteoarthritis
4. Pomegranate Juice Consumption May Improve Myocardial Ischemia
5. Drinking Real Juice Doesnt Cause Obesity In Children
6. Elements In Grape fruit Juice Combine Lethally with Certain Drugs, leading to potentially dangerous side effects, study.
7. Bone Strength Increases In Rats With Citrus Juice Breakfast – Study Say
8. Cherry Juice Could Reduce Muscle Damage Pain
9. Pomegranate Juice Remedy for Prostate Cancer
10. Muscle Pain? Drink Cherry Juice
11. Apple Juice May Keep Alzheimers Away
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/28/2017)... ... ... enough sleep affects much more than energy – it also has mental and physical benefits. ... motor reaction time, which can increase the risk of having a car accident. , ... the NSF to help you sleep better and feel better:, , ...
(Date:4/28/2017)... ... April 28, 2017 , ... ... http://www.wiredlifesolutions.com , “Computers are everywhere and they’re here to stay,” said ... Global Climate Change and Your Health on Voice America sponsored by Nature’s Tears® ...
(Date:4/28/2017)... (PRWEB) , ... April 28, 2017 , ... The ... board members and officers for 2017-2018. The annual board election process has been in ... a volunteer basis. , Thomas C. Dickerson, Ed.D., FACHE, succeeds Jim Hamilton, MHA, CMM, ...
(Date:4/28/2017)... ... April 28, 2017 , ... Children and adolescents who ... experiences than children in the general population. That’s because foster care is designed ... family challenges. While no fault of their own, youth who have experienced trauma ...
(Date:4/28/2017)... Harbor, Md. (PRWEB) , ... April 28, 2017 ... ... Care Association of America (UCAOA) and College of Urgent Care Medicine will host ... 2017 workshops, sessions and speakers will help those in the industry adapt to ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)... 2017  AbbVie (NYSE: ABBV), a global biopharmaceutical ... chronic hepatitis C virus (HCV) infected patients with ... compensated cirrhosis (Child-Pugh A) achieved sustained virologic response ... its investigational, pan-genotypic regimen of glecaprevir/pibrentasvir (G/P). These ... 12 weeks of G/P treatment without ribavirin. Patients ...
(Date:4/20/2017)... Sweden , April 20, 2017 ... NEVPF) ("NeuroVive") today announced positive preclinical results ... preclinical compound for non-alcoholic steatohepatitis (NASH), in ... NV556 has previously shown ... NASH model. Today, NeuroVive,s scientists present novel ...
(Date:4/19/2017)... , April 19, 2017 Cardiology devices segment ... projected period The Cardiology Devices segment is likely ... US$ 15 Mn in 2018 over 2017. By the end ... market valuation close to US$ 700 Mn, expanding at a ... segment dominated the Asia Pacific reprocessed ...
Breaking Medicine Technology: